We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Masco
MAS
$14B
| $6.77M | 0.01% |
+83,153
| New | +$5.8M |
|
1202
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
| $6.74M | 0.01% |
+42,480
| New | +$6.32M |
|
1203
Willis Towers Watson
WTW
$30.2B
| $6.74M | 0.01% |
+25,772
| New | +$6.89M |
|
1204
H&R Block
HRB
$5.66B
| $6.73M | 0.01% |
176,836
-959,708
| -84% | -$33.4M |
|
1205
Procept Biorobotics
PRCT
$1.22B
| $6.71M | 0.01% |
297,159
-401,073
| -57% | -$10M |
|
1206
Rogers Corp
ROG
$2.31B
| $6.69M | 0.01% |
+40,878
| New | +$5.62M |
|
1207
Newmark Group
NMRK
$2.69B
| $6.69M | 0.01% |
442,876
+274,111
| +162% | +$4.19M |
|
1208
JPMorgan Active Value ETF
JAVA
$7B
| $6.69M | 0.01% |
+84,252
| New | +$6.44M |
|
1209
OFG Bancorp
OFG
$2.22B
| $6.66M | 0.01% |
+135,801
| New | +$6.15M |
|
|
STLN
1210
Starling Oncology
STLN
$644M
| $6.64M | 0.01% |
1,222,498
+880,233
| +257% | +$3.7M |
|
1211
Expeditors International
EXPD
$24.2B
| $6.61M | 0.01% |
40,536
+14,071
| +53% | +$2.18M |
|
1212
AAR Corp
AIR
$5.26B
| $6.6M | 0.01% |
+46,191
| New | +$5.45M |
|
1213
Editas Medicine
EDIT
$465M
| $6.6M | 0.01% |
2,037,287
+1,826,979
| +869% | +$5.34M |
|
|
TBN
1214
Tamboran Resources
TBN
$1.4B
| $6.59M | 0.01% |
202,841
+89,407
| +79% | +$3.2M |
|
1215
Philip Morris
PM
$288B
| $6.59M | 0.01% |
36,408
+24,628
| +209% | +$4.27M |
|
1216
NetEase
NTES
$76.5B
| $6.58M | 0.01% |
51,319
+882
| +2% | +$104K |
|
1217
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $6.51M | 0.01% |
60,800
-676,362
| -92% | -$77.1M |
|
1218
Addus HomeCare
ADUS
$2.23B
| $6.51M | 0.01% |
64,793
+49,888
| +335% | +$4.71M |
|
1219
Leonardo DRS
DRS
$9.86B
| $6.51M | 0.01% |
152,502
-94,777
| -38% | -$4.21M |
|
1220
Magnite
MGNI
$3.4B
| $6.49M | 0.01% |
341,864
+299,396
| +705% | +$4.29M |
|
1221
Lindblad Expeditions
LIND
$1.74B
| $6.47M | 0.01% |
229,222
-570,165
| -71% | -$12M |
|
|
SAIL
1222
SailPoint Inc
SAIL
$10.1B
| $6.45M | 0.01% |
440,855
-104,567
| -19% | -$1.42M |
|
1223
SiTime
SITM
$18B
| $6.43M | 0.01% |
8,630
-6,305
| -42% | -$3.98M |
|
1224
National Health Investors
NHI
$3.51B
| $6.42M | 0.01% |
84,191
-49,950
| -37% | -$3.83M |
|
1225
Transportadora de Gas del Sur
TGS
$4.46B
| $6.39M | 0.01% |
214,939
+207,239
| +2,691% | +$6.42M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.